文献速递创伤与烧伤重症综合管理与镇静镇痛

创伤患者死亡原因的前瞻性多中心研究:为何死亡与如何死亡

The why and how our trauma patients die: A prospective Multicenter Western Trauma Association study.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论在18个创伤中心前瞻性登记中,创伤性脑损伤是总体首位死因(45%),失血性休克是院前和早期首位死因(44.7%),穿透伤患者死亡更早且以失血为主。

该研究由西部创伤协会在18个创伤中心前瞻性纳入2015年12月至2017年8月所有成年创伤死亡患者,由主治医师在死亡后立即按标准化定义判定主要及次要死因。共1536例,中位年龄55岁,74.5%为男性;跌倒最常见(26.6%),枪伤第二(24.3%)。总体首位主要死因为创伤性脑损伤(45%),其次为失血(23%);钝性伤患者更易以创伤性脑损伤为主要死因(47.8% vs 37.4%),穿透伤患者更易以失血为主要死因(51.7% vs 12.5%)。失血是院前(44.7%)和早期死亡(39.1%)的主要死因,创伤性脑损伤则是后期最常见死因。

要点

  • 总体首位主要死因为创伤性脑损伤(45%),其次为失血(23%),创伤性脑损伤中82.2%为不可存活。
  • 失血是院前死亡(44.7%)和早期死亡(39.1%)的首要死因,创伤性脑损伤是后期死亡首位原因。
  • 穿透伤患者中失血为主要死因的比例为51.7%,显著高于钝性伤患者的12.5%(p<0.0001)。
  • 钝性伤患者中创伤性脑损伤为主要死因的比例为47.8%,显著高于穿透伤患者的37.4%(p<0.0001)。
  • 穿透伤患者死亡更早,80.1%发生在第0天,而钝性伤患者为38.5%(p<0.0001)。

适用人群与场景

  • 18个创伤中心在2015年12月至2017年8月期间前瞻性纳入的所有成年创伤死亡患者(n=1536)。

研究设计与关键结果

  • 研究类型为前瞻性多中心研究,共18个创伤中心,纳入1536例成年创伤死亡患者,中位年龄55岁(四分位距32-75岁),74.5%为男性。
  • 穿透伤患者412例,较钝性伤患者年轻(32岁 vs 64岁,p<0.0001),男性比例更高(86.7% vs 69.9%,p<0.0001)。
  • 跌倒为最常见损伤机制(26.6%),枪伤第二(24.3%)。
  • 总体首位主要死因为创伤性脑损伤(45%),其次为失血(23%);创伤性脑损伤中82.2%为不可存活。
  • 钝性伤患者以创伤性脑损伤为主要死因的比例高于穿透伤患者(47.8% vs 37.4%,p<0.0001);穿透伤患者以失血为主要死因的比例高于钝性伤患者(51.7% vs 12.5%,p<0.0001)。
  • 失血为院前死亡(44.7%)和早期死亡(39.1%)的主要死因,创伤性脑损伤为后期死亡最常见原因。
  • 穿透伤患者80.1%在第0天死亡,钝性伤患者为38.5%(p<0.0001)。
  • 大多数死亡归因于疾病本身(69.3%),而非限制进一步积极治疗(30.7%);在因撤除治疗而死亡的患者中,失血是38.8%死亡的促发原因。

证据类型、等级与局限

  • 证据类型为前瞻性多中心流行病学研究,证据等级为II级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对死因进行实时判定对于真实理解患者结局、中心绩效和未来研究至关重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Historically, hemorrhage has been attributed as the leading cause (40%) of early death. However, a rigorous, real-time classification of the cause of death (COD) has not been performed. This study sought to prospectively adjudicate and classify COD to determine the epidemiology of trauma mortality.

METHODS: Eighteen trauma centers prospectively enrolled all adult trauma patients at the time of death during December 2015 to August 2017. Immediately following death, attending providers adjudicated the primary and contributing secondary COD using standardized definitions. Data were confirmed by autopsies, if performed.

RESULTS: One thousand five hundred thirty-six patients were enrolled with a median age of 55 years (interquartile range, 32-75 years), 74.5% were male. Penetrating mechanism (n = 412) patients were younger (32 vs. 64, p < 0.0001) and more likely to be male (86.7% vs. 69.9%, p < 0.0001). Falls were the most common mechanism of injury (26.6%), with gunshot wounds second (24.3%). The most common overall primary COD was traumatic brain injury (TBI) (45%), followed by exsanguination (23%). Traumatic brain injury was nonsurvivable in 82.2% of cases. Blunt patients were more likely to have TBI (47.8% vs. 37.4%, p < 0.0001) and penetrating patients exsanguination (51.7% vs. 12.5%, p < 0.0001) as the primary COD. Exsanguination was the predominant prehospital (44.7%) and early COD (39.1%) with TBI as the most common later. Penetrating mechanism patients died earlier with 80.1% on day 0 (vs. 38.5%, p < 0.0001). Most deaths were deemed disease-related (69.3%), rather than by limitation of further aggressive care (30.7%). Hemorrhage was a contributing cause to 38.8% of deaths that occurred due to withdrawal of care.

CONCLUSION: Exsanguination remains the predominant early primary COD with TBI accounting for most deaths at later time points. Timing and primary COD vary significantly by mechanism. Contemporaneous adjudication of COD is essential to elucidate the true understanding of patient outcome, center performance, and future research.

LEVEL OF EVIDENCE: Epidemiologic, level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Callcut RA, Kornblith LZ, Conroy AS, et al. The why and how our trauma patients die: A prospective Multicenter Western Trauma Association study. J Trauma Acute Care Surg. 2019. PMID: 30633095. doi:10.1097/TA.0000000000002205

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。